TRACY GIESE: Open Payments
NPI 1124492608 · INDEPENDENCE, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$724 in 24 payments from 9 companies in 2025. Trend: 2023 $1,569 · 2024 $986 · 2025 $724
Food & beverage: $681Education: $43
| Company | Payments | Amount |
|---|---|---|
| Dexcom, Inc. | 4 | $182 |
| Mannkind Corporation | 8 | $150 |
| Novo Nordisk Inc | 2 | $139 |
| Tandem Diabetes Care, Inc. | 3 | $61 |
| Corcept Therapeutics | 2 | $54 |
| CeQur Corporation | 1 | $52 |
| Abbott Laboratories | 2 | $45 |
| Insulet Corporation | 1 | $24 |
| Medtronic, Inc. | 1 | $18 |
Products named: Dexcom G6 Transmitter, AFREZZA, Ozempic, t:slim X2 Insulin Pump with Control-IQ, Korlym, CeQur Simplicity, FREESTYLE LIBRE 3, Omnipod.
Industry payments across MO — which companies pay providers there.
